Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Decrease in the Apparent Diffusion Coefficient in Peritumoral Edema for the Assessment of Recurrent Glioblastoma Treated by Bevacizumab

    Purposes: Anti-edema effect of bevacizumab was evaluated using the apparent diffusion coefficient (ADC) of peritumoral edema associated with regional cerebral blood flow (rCBV) of the tumor.

    Shingo Takano MD, PhD, Hidehiro Kimu, Kyoji Tsuda, Satoru Osuka in Brain Edema XV (2013)